The Medicine Maker. Onward in Oncology: Lessons Learned with Carlo Toniatti

Lessons Learned With Carlo Toniatti

The Medicine Maker. Onward in Oncology: Lessons Learned with Carlo Toniatti

IRBM’s Chief Science Officer, Carlo Toniatti is once again featured in the Medicine Maker. This time he takes us on a journey from the clinic, to academia, to industry – where he spent over two decades developing anti-cancer drugs. Carlo shares the lessons he learned along the way.

Read the article in full here

IRBM EDITORIAL

Related Posts

IRBM To Collaborate With MSD To Develop Peptides Against Coronavirus
IRBM to collaborate with MSD to develop peptides against coronavirus
Builds on Research to Combat Severe Acute Respiratory Syndrome (SARS)
Rome, Italy – IRBM, a global Contract Research Organization today announced a new research collaboration agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA) to identify and develop novel peptide therapeutics active against different strains of coronavirus, including SARS-CoV-2.
Back To Top